Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Euro Log Regulatory News (ASLI)

Share Price Information for Abrdn Euro Log (ASLI)

Share Price is delayed by 15 minutes
Get Live Data
18.70    0.38 (2.07%)
Bid:
18.34
Ask:
18.70
Spread: 0.36 (1.963%)
Market Cap: £77.08m
ASLI Live PriceLast checked at - London Stock Exchange

Intraday Abrdn Euro Log Share Chart

PrimaryBid Offer

10 Mar 2021 07:01

RNS Number : 7131R
Aberdeen Standard Eur Lgstc Inc PLC
10 March 2021
 

 

THIS ANNOUNCEMENT, INCLUDING THE APPENDICES AND THE INFORMATION IN THEM, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.

FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION.

THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY PRIMARYBID LIMITED, WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRN 779021)

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (AS IT FORMS PART OF DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRWAL) ACT 2018). UPON PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED IN THE PUBLIC DOMAIN.

 

10 March 2021

LEI: 213800I9IYIKKNRT3G50

 

Aberdeen Standard European Logistics Income PLC

 (LON: ASLI)

PrimaryBid Offer

 

The Board of Aberdeen Standard European Logistics Income PLC (the "Company" or "ASLI"), is pleased to announce an offer for subscription via the PrimaryBid platform (the "PrimaryBid Offer") of new ordinary shares of £0.01 each in the capital of the Company (the "New Ordinary Shares").

As separately announced earlier today, the Board of ASLI announced that it proposes to raise additional equity capital through the issue of New Ordinary Shares in the capital of the Company by way of a non-pre-emptive Issue (the "Issue").

The number of New Ordinary Shares to be issued and the price per New Ordinary Share (the "Strike Price") will be agreed between Investec Bank plc, in its capacity as broker to ASLI, and the Company following the close of the book-build at noon on Friday 12 March 2021 and announced shortly thereafter.

Given the above, and in light of the attractive pipeline of investment opportunities that the Investment Manager is continuing to evaluate, the Board believes that it is an appropriate point at which to seek to raise further equity capital through the issue of New Ordinary Shares.

PrimaryBid Offer

Private investors, who are either professionally advised or financially sophisticated, may participate in the PrimaryBid Offer by applying exclusively through the PrimaryBid platform and the PrimaryBid mobile app available on the Apple App Store and Google Play. PrimaryBid does not charge investors any commission for this service.

The PrimaryBid Offer, which is being made by the Company via the PrimaryBid.com platform, is now open and will close at noon on 12 March 2021. The PrimaryBid Offer may close early if it is oversubscribed.

There is a minimum subscription of £1,000 per investor under the terms of the PrimaryBid Offer which is open to private investors who are either professionally advised or financially sophisticated. The Company reserves the right to scale back any order at its absolute discretion. The Company and PrimaryBid each also reserve the right to reject any application for subscription under the PrimaryBid Offer without giving any reason for such rejection. Aggregate demand under the PrimaryBid Offer will be limited to EUR 8m (or the sterling equivalent), as is legally required.

No commission will be charged to investors on applications to participate in the PrimaryBid Offer. It is important to note that once an application for New Ordinary Shares has been made and accepted via PrimaryBid, it cannot be withdrawn.

The New Ordinary Shares will be issued free of all liens, charges and encumbrances and will, when so issued, be fully paid and rank pari passu in all respects with each other and with the Company's existing ordinary shares including, without limitation, the right to receive all dividends and other distributions declared, made or paid after the date of issue. 

Application will be made to the Financial Conduct Authority for admission of the New Ordinary Shares to the premium segment of the Official List and to London Stock Exchange plc for admission to trading of the New Ordinary Shares on its main market for listed securities (the "Main Market"), (together, "Admission"). It is expected that Admission will become effective, and that dealings in the New Ordinary Shares on the Main Market will commence, on or around 16 March 2021.

The terms and conditions on which the PrimaryBid Offer is made, including the procedure for application and payment for New Ordinary Shares, is available at www.PrimaryBid.com.

Aberdeen Asset Management PLC

Luke Mason

Gary Jones

 

 

+44 (0) 20 7463 6000

PrimaryBid Limited

James Deal

Fahim Chowdhury

 

 

+ 44 (0) 203 026 4750

This Announcement should be read in its entirety. In particular, the information provided in the "Important Notices" section of this announcement should be read and understood.

Important Notices

This Announcement has been issued by and is the sole responsibility of the Company.

Persons distributing this announcement must satisfy themselves that is lawful to do so. This Announcement is for information purposes only and shall not constitute an offer to sell or issue or the solicitation of an offer to buy, subscribe for or otherwise acquire securities in any jurisdiction in which any such offer or solicitation would be unlawful. Any failure to comply with this restriction may constitute a violation of the securities laws of such jurisdictions. Persons needing advice should consult an independent financial adviser.

The distribution of this announcement and the offering, placing and/or issue of the New Ordinary Shares in certain jurisdictions may be restricted by law. No action has been taken by the Company or any of its affiliates, agents, directors, officers or employees that that would permit an offer of the New Ordinary Shares or possession or distribution of this announcement or any other offering or publicity material relating to such New Ordinary Shares in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by the Company to inform themselves about and to observe any such restrictions.

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (COLLECTIVELY, THE "UNITED STATES"), AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR JERSEY OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION. THIS ANNOUNCEMENT HAS NOT BEEN APPROVED BY THE LONDON STOCK EXCHANGE, NOR IS IT INTENDED THAT IT WILL BE SO APPROVED.

This announcement or any part of it does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in the United States, Canada, Australia, the Republic of South Africa, Japan or any other jurisdiction in which the same would be unlawful. No public offering of the securities referred to herein is being made in any such jurisdiction.

This communication is not an offer of securities for sale in the United States. The securities referred to herein have not been and will not be registered under the US Securities Act 1933, as amended (the "Securities Act") or under the securities laws of any state or other jurisdiction of the United States, and may not be offered or sold directly or indirectly in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with the securities laws of any state or any other jurisdiction of the United States. No public offering of securities is being made in the United States,

Certain statements contained in this announcement constitute "forward-looking statements" with respect to the financial condition, performance, strategic initiatives, objectives, results of operations and business of the Company. All statements other than statements of historical facts included in this announcement are, or may be deemed to be, forward-looking statements. Without limitation, any statements preceded or followed by or that include the words "targets", "plans", "believes", "expects", "aims", "intends", "anticipates", "estimates", "projects", "will", "may", "would", "could" or "should", or words or terms of similar substance or the negative thereof, are forward-looking statements. Forward-looking statements include statements relating to the following: (i) future capital expenditures, expenses, revenues, earnings, synergies, economic performance, indebtedness, financial condition, dividend policy, losses and future prospects; and (ii) business and management strategies and the expansion and growth of the Company's operations. Such forward-looking statements involve risks and uncertainties that could significantly affect expected results and are based on certain key assumptions. Many factors could cause actual results, performance or achievements to differ materially from those projected or implied in any forward-looking statements. The important factors that could cause the Company's actual results, performance or achievements to differ materially from those in the forward-looking statements include, among others, the macroeconomic and other impacts of COVID-19, economic and business cycles, the terms and conditions of the Company's financing arrangements, foreign currency rate fluctuations, competition in the Company's principal markets, acquisitions or disposals of businesses or assets and trends in the Company's principal industries. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. In light of these risks, uncertainties and assumptions, the events described in the forward-looking statements in this announcement may not occur. The forward-looking statements contained in this announcement speak only as of the date of this announcement. The Company and its directors each expressly disclaim any obligation or undertaking to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, unless required to do so by applicable law or regulation, the Listing Rules, the Market Abuse Regulation, the Disclosure Guidance and Transparency Rules, the rules of the London Stock Exchange or the UK Financial Conduct Authority.

Any indication in this announcement of the price at which ordinary shares have been bought or sold in the past cannot be relied upon as a guide to future performance. No statement in this announcement is intended as a profit forecast or estimate for any period and no statement in this announcement should be interpreted to mean that earnings, earnings per share or income, cash flow from operations or free cash flow for the Company, as appropriate, for the current or future years would necessarily match or exceed the historical published earnings, earnings per share or income, cash flow from operations or free cash flow for the Company.

Neither the content of the Company's website (or any other website) nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement. The New Ordinary Shares to be issued or sold pursuant to the PrimaryBid Offer will not be admitted to trading on any stock exchange other than the London Stock Exchange.

Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice.

It should be noted that a subscription for New Ordinary Shares and investment in the Company carries a number of risks. Investors should consider the risk factors set out on PrimaryBid.com before making a decision to subscribe for New Ordinary Shares. Investors should take independent advice from a person experienced in advising on investment in securities such as the New Ordinary Shares if they are in any doubt. 

 

 

END

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEDZGGFLLMGMZM
Date   Source Headline
1st Jun 20263:56 pmRNSResult of AGM
28th May 20267:00 amRNSUnaudited Net Asset Value as at 31 March 2026
18th May 20269:38 amRNSConfirmation of €23.5m warehouse sale in Ede
6th May 20267:00 amRNSConditional sale and fourth interim dividend
28th Apr 202611:26 amRNSDoc re. Annual Report
24th Apr 20264:10 pmRNS5th capital distribution by way of B Share scheme
22nd Apr 20267:00 amRNSFinal Results
13th Apr 20267:00 amRNSUnaudited Net Asset Value as at 31 December 2025
20th Mar 20269:53 amRNSDisposal of Warehouse in Noves, France
16th Mar 20263:30 pmRNSDisposal of Dutch Asset
16th Mar 20263:30 pmRNSDisposal of Dutch Asset
20th Feb 202612:30 pmRNSResult of Requisitioned General Meeting
28th Jan 20267:00 amRNSPublication of Circular/Notice of General Meeting
23rd Jan 20269:00 amRNSDisposal of further French asset
12th Jan 20264:00 pmRNSNotice of Requisition of a General Meeting
12th Jan 20267:00 amRNSSale of French Assets
17th Dec 20257:00 amRNSResponse to DL Invest Group
2nd Dec 202510:40 amRNS4th capital distribution by way of B Share scheme
27th Nov 20253:33 pmRNSHolding(s) in Company
20th Nov 20257:00 amRNSAnnouncement of Interim Dividend
3rd Nov 20257:00 amRNSSale of Polish Assets
27th Oct 20257:00 amRNSEstimated Unaudited NAV as at 30 September 2025
22nd Oct 202510:23 amRNSHolding(s) in Company
20th Oct 20254:00 pmRNSHolding(s) in Company
20th Oct 20254:00 pmRNSHolding(s) in Company
13th Oct 202511:59 amRNSDoc re. Half Yearly Report
29th Sep 20257:00 amRNSHalf-year Report
3rd Sep 20255:35 pmRNSReplacement Unaudited NAV as at 30 June 2025
3rd Sep 20257:00 amRNSUnaudited NAV as at 30 June 2025
29th Aug 20257:00 amRNSThird B Share Distribution
18th Aug 20259:35 amRNSDeclaration of Interim Distribution
6th Aug 20257:00 amRNSContinued Sales Momentum & Disposal Process Update
31st Jul 20257:00 amRNSPortfolio Sales Update
16th Jul 20259:24 amRNSPortfolio Sales and Second B Share Distribution
11th Jul 202511:44 amRNSHolding(s) in Company
11th Jul 20257:00 amRNSPortfolio Sales Update
2nd Jul 20253:33 pmRNSReplacement Result of AGM
25th Jun 20252:15 pmRNSResult of AGM
11th Jun 202510:20 amRNSHolding(s) in Company
28th May 20257:00 amRNSUnaudited NAV as at 31 March 2025
19th May 202510:02 amRNSFirst Interim Dividend Declaration
6th May 202510:18 amRNSDirector Declaration
1st May 20254:22 pmRNSDoc re. Annual Report
11th Apr 20257:00 amRNSAnnual Financial Report
2nd Apr 20257:00 amRNSB Share Scheme Apportionment Ratio
26th Mar 20252:52 pmRNSHolding(s) in Company
27th Feb 20257:00 amRNSB Share Scheme First Distribution
24th Feb 20257:00 amRNSUnaudited Net Asset Value as at 31 December 2024
17th Feb 20257:00 amRNSFourth Interim Distribution
29th Jan 20254:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.